KIORA PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
KIORA PHARMACEUTICALS, INC. (KPRX) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.03% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-25
- KIORA PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was 0.03%, a 96.05% decline from fiscal 2023.
- KIORA PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was 0.76%.
- KIORA PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.26%, a 116.15% decline from fiscal 2021.
- KIORA PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was 1.61%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 0.03% 10-K · filed 2026-03-25 | |
| 2023-12-31 | 0.76% 10-K · filed 2025-03-25 | |
| 2022-12-31 | -0.26% 10-K · filed 2024-03-25 | |
| 2021-12-31 | 1.61% 10-K · filed 2023-03-23 | 1.36% 10-K · filed 2022-04-15 |
| 2020-12-31 | -4.50% 10-K/A · filed 2022-07-07 | -4.49% 10-K · filed 2021-03-25 |
| 2019-12-31 | -0.43% 10-K · filed 2021-03-25 | |
| 2018-12-31 | -2.65% 10-K · filed 2020-03-04 | |
| 2017-12-31 | -3.91% 10-K · filed 2019-03-01 | |
| 2016-12-31 | -1.43% 10-K · filed 2018-03-02 | |
| 2015-12-31 | -0.24% 10-K · filed 2017-02-23 | |
| 2014-12-31 | -2.60% 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |